Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court Decisions That Leave Life Sciences Industry Under Cloud Of Uncertainty

June 25, 2014

Read the full article (PDF) >

San Diego (June 25, 2014) – Bloomberg BNA and law firm Robins, Kaplan, Miller & Ciresi L.L.P., in conjunction with the Biotechnology Industry Organization, today published a study on the impact of recent U.S. Supreme Court decisions affecting the life sciences industry. The report, Stopped at the Threshold: The Practical Impact of the Supreme Court’s Mayo and Myriad Decisions on Biotechnology Patent Practices, explores the impact of Supreme Court decisions handed down in 2012 and 2013 that have made it more difficult for companies in the multibillion dollar global life sciences industry to obtain patents.

©2014. Used with permission from Bloomberg BNA.

Related Publications

January 18, 2022
Briefly: A User's Guide for Post-Trial Motions
Eric Magnuson and Caroline Moos - Minnesota Lawyer
December 21, 2021
Is This the End of Mandatory Arbitration?
David Rochelson - Antitrust, Vol. 36, No. 1, Fall 2021
December 2021
The Evolution and Practical Application of Genetic Testing
Teresa Fariss McClain - The Robins Kaplan Justice Report
Winter 2021
Avoiding Guilt by Association
Denise Rahne - The Robins Kaplan Spotlight, Vol. 6, No. 4
Winter 2021
Can You Keep a Secret? And Should You?
Anne Lockner - The Robins Kaplan Spotlight, Vol. 6, No. 4
Back to Top